Format

Send to

Choose Destination
Trends Immunol. 2014 Sep;35(9):443-50. doi: 10.1016/j.it.2014.07.004. Epub 2014 Aug 8.

Host defense peptides: front-line immunomodulators.

Author information

1
Centre for Microbial Diseases and Immunity Research, 2259 Lower Mall Research Station, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada.
2
Centre for Microbial Diseases and Immunity Research, 2259 Lower Mall Research Station, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada. Electronic address: bob@hancocklab.com.

Abstract

Although first studied for their antimicrobial activity, host defense peptides (HDPs) are now widely recognized for their multifunctional roles in both the innate and adaptive immune responses. Their diverse immunomodulatory capabilities include the modulation of pro- and anti-inflammatory responses, chemoattraction, enhancement of extracellular and intracellular bacterial killing, cellular differentiation and activation of the innate and adaptive compartments, wound-healing, and modulation of autophagy as well as apoptosis and pyroptosis. We review the various immunomodulatory roles of HDPs and their synthetic analogs, the innate defense regulators (IDRs). We discuss their potential as host-directed therapies, the hurdles they face in clinical development, and propose ways forward.

PMID:
25113635
DOI:
10.1016/j.it.2014.07.004
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center